Stevanato Group to Present at Upcoming Investor Conferences
24 Mai 2023 - 10:01PM
Business Wire
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider
of drug containment, drug delivery, and diagnostic solutions to the
pharmaceutical, biotechnology, and life sciences industries,
announced today that it will participate in two upcoming investor
conferences.
On June 6, 2023, management will present at the 43rd Annual
William Blair Growth Stock Conference in Chicago, Illinois at 2:40
p.m. CT, and on June 8, 2023, management will present at the
Jefferies Healthcare Conference in New York, New York at 1:30 p.m.
ET.
A live audio webcast of each presentation will be available on
the Company’s website at www.stevanatogroup.com under the
"Investors" section. A replay of each presentation will be
available for approximately 90 days after the event.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of
drug containment, drug delivery and diagnostic solutions to the
pharmaceutical, biotechnology and life sciences industries. The
Group delivers an integrated, end-to-end portfolio of products,
processes and services that address customer needs across the
entire drug life cycle at each of the development, clinical and
commercial stages. Stevanato Group’s core capabilities in
scientific research and development, its commitment to technical
innovation and its engineering excellence are central to its
ability to offer value added solutions to clients.
For more information, please visit www.stevanatogroup.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230524005512/en/
Media Stevanato Group media@stevanatogroup.com
Investor Relations Lisa Miles
lisa.miles@stevanatogroup.com
Stevanato (NYSE:STVN)
Historical Stock Chart
Von Apr 2024 bis Mai 2024
Stevanato (NYSE:STVN)
Historical Stock Chart
Von Mai 2023 bis Mai 2024